Advent Life Sciences gets re-up for latest fund

The fund closed in November 2010 on £75m. This latest commitment from a new institutional investor, combined with a re-up from existing LPs, brings the fund to an aggregate amount of £101.3m and exceeds the initial £75m target.

The fund was launched in summer 2009 and closed 15 months later in what was described as a challenging venture fundraising environment.

Advent Life Sciences Fund I is the first dedicated life sciences fund raised by the firm. It will invest in early- and mid-stage life sciences companies in the UK, Europe and the US. Drug discovery, enabling technologies, med-tech and diagnostics were reported as some of the sectors the fund will invest in.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Venture
• Advent Venture Partners